Write to Us

    Your Name (required)

    Your Email (required)


    Your Message

    Contact Us

    Matrix II, unit 1.10
    Science Park 400
    1098 XH Amsterdam
    The Netherlands


    Phone No: +31 20 7400 778

    Follow Us on Twitter

    February 25, 2015
    Cost effective health model

    Market access and reimbursement report

    A medical device company has developed a new technology that could improve the visualization and treatment of the affected heart tissue during catheter ablations of the left atrium of the heart. They were interested in getting an overview of the market access and reimbursement regulations in the Netherlands and Belgium […]
    February 25, 2015
    Health Technology Assessment

    Cost-effectiveness and budget impact model for a diagnostic test

    Allergic Rhinitis (AR) is a condition where an inflammatory reaction of the immune system is caused by specific allergens. Respiratory AR affects around 15% of the people in the Netherlands. Mostly, AR is treated with symptomatic treatment, but immunotherapy potentially offers a curative treatment by minimizing sensitivity to the allergen. […]
    September 7, 2014

    Panaxea at ISPOR Amsterdam, 10-13 November 2014

    Panaxea will be one of the exhibiting organizations at the 17th Annual ISPOR European Congress in Amsterdam (RAI). Visit our booth #913  
    September 2, 2014

    New office

    Our office has been relocated to a new address! Hengelosestraat 221 7521 AC Enschede The Netherlands  [su_gmap address=”Hengelosestraat 221″]
    January 22, 2014
    Health Economic Modeling

    Health Economic Modeling

    For a global health company we evaluated the expected incremental cost-effectiveness of one of their products. The cost-effectiveness outcome was needed to support adjuvant therapy decision making versus current clinical practice in the Netherlands. We… developed a Markov model to project distant recurrences survival, quality-adjusted life expectancy and direct medical […]
    January 22, 2014
    Time-and-motion study

    Time-and-motion study

    For a large pharmaceutical company, Panaxea was asked to perform a time-and-motion study to compare two administration methods of medicine.
    January 22, 2014

    Impact-analysis public-private partnership (PPP)

    In this project we performed an impact-analysis on scientific, translational/clinical and socio-economic aspects of a public-private partnership (PPP)
    January 22, 2014

    Health economic analysis of a POCT assay

    Point of Care Testing (POCT) is generally perceived to be more expensive on a unit-cost base than testing performed in a centralized laboratory. Consequently, introducing a new treatment protocol in the hospital setting, involving an increase in the number of POCT analyses performed, requires a thorough analysis of accompanying costs […]
    January 22, 2014
    Decision analytic support model

    Decision analytic support model to guide implementation of laboratory assay

    Decision analytic support model could be populated with hospital-specific data, and could thereby guide implementation decisions at local and hospital level